Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wonder P Drake

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 15, 2024
A Promising Biomarker for Pulmonary Sarcoidosis That Must Cross the Finish LineLisa Maier, Wonder P Drake
American Journal of Respiratory and Critical Care Medicine|September 16, 2015
Solving the Conundrum: Immunogenetics of SarcoidosisNaftali Kaminski, Wonder P Drake
Immunotherapy|January 10, 2015
Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?Lindsay J Celada, Wonder P Drake
The Yale Journal of Biology and Medicine|June 29, 2017
Role of Microbial Agents in Pulmonary Fibrosis
Ozioma S Chioma, Wonder P Drake
American Journal of Respiratory and Critical Care Medicine|July 11, 2024
Renin-Angiotensin-Aldosterone System: A Potential Source of Biomarkers and Therapeutic Targets for SarcoidosisShaikh M Atif, Wonder P Drake
Current Opinion in Pulmonary Medicine|May 18, 2010
Vitamin D, innate immunity, and sarcoidosis granulomatous inflammation: insights from mycobacterial researchBradley W Richmond, Wonder P Drake
Seminars in Respiratory and Critical Care Medicine|July 29, 2010
The etiologic role of infectious antigens in sarcoidosis pathogenesisKyra A Oswald-Richter, Wonder P Drake
American Journal of Respiratory and Critical Care Medicine|November 17, 2011
Where next for gene expression profiling? So much promiseImre Noth, Kevin F Gibson, Wonder P Drake
Clinics in Chest Medicine|November 24, 2015
The Etiologic Role of Infectious Antigens in Sarcoidosis PathogenesisLindsay J Celada, Charlene Hawkins, Wonder P Drake
Journal of Autoimmunity|May 31, 2024
Infectious and non-infectious precipitants of sarcoidosisOzioma S Chioma, ZaDarreyal Wiggins, Samantha Rea, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Respiratory and Critical Care Medicine|May 15, 2024
A Promising Biomarker for Pulmonary Sarcoidosis That Must Cross the Finish LineLisa Maier, Wonder P Drake
American Journal of Respiratory and Critical Care Medicine|September 16, 2015
Solving the Conundrum: Immunogenetics of SarcoidosisNaftali Kaminski, Wonder P Drake
Immunotherapy|January 10, 2015
Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?Lindsay J Celada, Wonder P Drake
The Yale Journal of Biology and Medicine|June 29, 2017
Role of Microbial Agents in Pulmonary Fibrosis
Ozioma S Chioma, Wonder P Drake
American Journal of Respiratory and Critical Care Medicine|July 11, 2024
Renin-Angiotensin-Aldosterone System: A Potential Source of Biomarkers and Therapeutic Targets for SarcoidosisShaikh M Atif, Wonder P Drake
Current Opinion in Pulmonary Medicine|May 18, 2010
Vitamin D, innate immunity, and sarcoidosis granulomatous inflammation: insights from mycobacterial researchBradley W Richmond, Wonder P Drake
Seminars in Respiratory and Critical Care Medicine|July 29, 2010
The etiologic role of infectious antigens in sarcoidosis pathogenesisKyra A Oswald-Richter, Wonder P Drake
American Journal of Respiratory and Critical Care Medicine|November 17, 2011
Where next for gene expression profiling? So much promiseImre Noth, Kevin F Gibson, Wonder P Drake
Clinics in Chest Medicine|November 24, 2015
The Etiologic Role of Infectious Antigens in Sarcoidosis PathogenesisLindsay J Celada, Charlene Hawkins, Wonder P Drake
Journal of Autoimmunity|May 31, 2024
Infectious and non-infectious precipitants of sarcoidosisOzioma S Chioma, ZaDarreyal Wiggins, Samantha Rea, et al.
Pageof 6